Does Allopurinol Prolong a Treated, Acute Gout Flare?
Completed · Phase 4 · Has a placebo group
Conditions studied: Gout
In brief
This is a double blind placebo controlled study to determine whether starting allopurinol during a treated acute gout attack will have any effect on the duration of the attack.
Key facts
- Study ID
- NCT01988402
- Run by
- 59th Medical Wing
- People needed
- 35
- Starts
- 2007-12-01
- Expected to finish
- 2013-06-01
- Last updated by the study team
- 2018-02-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may not qualify if…
- Inability to return for examinations
- Glomerular filtration rate (calculated) less than 50 milliliters per minute
- Allopurinol use in past 6 months
- Ongoing cancer therapy
- Concomitant azathioprine or cyclophosphamide
- Any one of the following liver enzymes greater than 1.25 times the upper limit of normal:
- AST [Aspartate aminotransferase]
- ALT [Alanine aminotransferase]
- alkaline phosphatase
- Pre-gout pain in involved joint of more than 3 on a scale of 1-10
- Neurologic deficit around the involved joint
Where it is running
- Wilford Hall Ambulatory Surgical Center — Lackland Air Force Base, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.